COVID-19: Validation of a rapid test and immunoenzymatic tests (ELISA) IgG, igM and IgA for the diagnosis of Sars-CoV-2 infection, in the various forms of the disease and in asymptomatic positive and negative individuals by rtPCR (test gold standard) various forms of the disease and in asymptomatic individuals with a positive gold pattern (rtPCR)
- Funded by FAPEMIG Brazil
- Total publications:0 publications
Grant number: APQ-00489-20
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$18,263.31Funder
FAPEMIG BrazilPrincipal Investigator
Dulciene Maria De Magalhães QueirozResearch Location
BrazilLead Research Institution
Universidade Federal de Minas GeraisResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable